(MENAFNEditorial)
Second Notice of Annual Shareholders Meeting
Cal-X Stars Business Accelerator Inc. a California Corporation
Notice is hereby given that the annual general meeting of the shareholders of all classes of stock of Cal-X Stars Business Accelerator Inc. will be held at ROC Santa Monica 604 Arizona Ave Santa Monica CA 90401 on Friday April 29th 2016 at 3pm PST for the purpose of:
1. Receiving and considering the annual report and financial statements for the year ended Dec. 31st 2015 and report of board assigned task force committees including any audits thereon;
2. Electing directors;
3. Executive compensation approval; stock option plans for advisors consultants and employees approval;
shareholder loans to company promissory notes review and approval;
4. Major material supply and distribution agreements approval;
5. Re-appointing corporate accountant and legal counsel and;
6. Transacting such further and other business as may properly come before the meeting or any adjournment thereof including 2016 portfolio progress review and forward major goals.
Here is a link to a table of the Leonhardt Ventures's Cal-X Stars Business Accelerator Inc. 2016 Portfolio Class of 26 Regenerative Medtech and 4 Regenerative Economy Startups with current valuations and target goals valuations for the end of 2019 - which includes hyperlinks to all the individual startup web sites.
Emailed to all shareholders of record March 25th 2016. On behalf of the board of directors
· Dial-in Number: (712) 775-7031
· Access Code: 405-822-417
Chairman of the Board: Howard J. Leonhardt - eSigned - Howard J. Leonhardt
Secretary & Treasurer: Sofia Yepes - eSigned - Sofia J. Yepes
Board Directors: Jeremy Koff Tricia Nordy Jeff Donofrio Dr. Mark Cunningham
Committees: Compensation = Chair Jeremy Koff Tricia Nordy Jeff Donofrio Sunshine Act Compliance = Chair Ken Evans Sofia Yepes Dr. Mark Cunningham Audit = TBD
2016 Nominated Additional Board Member: Alex Richardson
Board Meeting Attending Non-Voting Advisors: Ken Evans Paul Norman
Valuation Growth Progress - ...
Cardiovascular Regenerative Medtech Portfolio Startups (excluding Bioheart) -
2013 = $3000000
2015 = $55100000
2016 = $224700000
2019 - $13.6 billion Target Goal
Regenerative Economy Portfolio Startups -
2013 = $1000000
2015 = $38186500
2016 = $93000000
2019 = $2.4 billion Target Goal
Valuation Methodology and Comparable Data = WorthWorm Pre-Money Valuation Software Silicon Valley Bank Reports VC Experts PitchBook Gust Angel Financing Reports Angelist Industry Related Press Releases Cayenne Consultuing Valuation Calculator Fierce Biotech and BioMed Reports. Wilson Sonsini Reports - http://worthworm.com/what-is-a-pre-money-valuation/ www.svb.com/healthcare-report/ https://pitchbook.com/news/reports/2h-2015-vc-valuations-trends-report https://angel.co/valuations https://www.caycon.com/valuation.php#bottom
Regenerative Medtech Portfolio (26)
1. BioLeonhardt MyoStim - heart and limb regeneration - 2012 (origin 1985)
2. CerebraCell - brain regeneration - 2015
3. Stem Cell Bra - breast regeneration - 2013
4. EyeCell - eye regeneration - 2015
5. AortaCell - aorta regeneration - 2012 (origin 2001)
6. BioPace - biological pacemaker regeneration - 2012 (origin 1998)
7. Valvublator - heart valve regeneration - 2012 (origin 1988)
8. CoroStim - vibrational energy to prevent clots plaque calcification - 2012 (origin 1986)
9. HeartScore - genomics based heart failure management - 2013
10. DentaCell - dental gum regeneration + tooth pulp storage - 2014
11. OrthodontiCell - cuts in half dental brace and aligner wearing time - 2015
12. PancreaCell - pancreas regeneration - 2015
13. RegenaLung - lung regeneration - 2015
14. CancerCell - bioelectric cancer tumor treatment + regeneration - 2016
15. EndoCell - artery regeneration - 2013
16. MyoStim ED - erectile dysfunction treatment - 2015
17. MyoStim Skin - skin regeneration - 2015
18. MyoStim Peripheral - limb blood flow improvement - 2011 (origin 1985)
19. LVSens - heart sensors - 2013
20. Cardiobridge* - circulating assist pump (note - this startup is not LV controlled) - 2012 (origin 2005)
21. HairCell - hair regeneration - 2016
22. Leonhardt-Wetling* Peripheral - wireless diabetic foot ulcer treatment - 2014
23. BioLeonhardt Whole Body Regeneration - Whole body regeneration - 2015
24. LiverCell - liver regeneration - 2016
25. KidneyCell - kidney regeneration - 2016
26. EarCell - ear hearing regeneration - 2016
Regenerative Economy Porfolio (4)
1. The California Stock Exchange TM - social good stock exchange and crowdfunding - 2011
a. Cal-X Crowdfund Connect - 2012
b. Cal-X Social Good Impact Fund powered by Motif Investing - 2015
c. Cal-X Microloans - 2014 in collaboration with ZimpleMoney
d. Cal-X Funders Syndicate - 2014
e. Cal-X Coffee Shops - 2014
f. CalXports -2013
g. PRETAIL Fashion - 2015
2. Cal-X Stars Business Accelerator Inc. - regenerative medtech and economy startup incubators and accelerarators - 2012
a. CalXelerator - 2013
b. SciAccelerator - 2016
c. Leonhardt's Launchpads NorCal @ University of Northern California Science Technology Innovation Center - 2007
d. Leonhardt's Launchpads Utah - 2016
e. LABioHub - 2015
f. Startup California - 2011
g. Leonhardt's Launchpads Georgia?
3. Kindheart Lionheart Media & Publishing Co. - Social good media- 2006
a. The Kindheart Lionheart TV Network - 2014
> California Love TV Program - 2014
> Love Dialogues TV Program - 2015
> Love Roller Coaster TV Program - 2015
> LIONS DEN Startup Pitch TV Program - 2015
> The Kindheart Lionheart TV and Radio Program - 2013
b. Kindheart Lionheart Book Club - 2006
c. Kindheart Lionheart Startup Media Support Services - 2014
d. Kindheart Lionheart Adventures - 2001
e. Radio Veronica USA + Radio Santa Monica USA - 2010
f. Wine Country Baseball - 2009
g. Dolphin Smiles: The Legend of Kindheart Lionheart - book screenplay potential movie & TV show - 1997
4. Leonhardt Food & Beverage
a. Lucille's American Cafe's* - 1996
b. Food Trikes & Scooters - 2013
c. V-Leonhardt Bus - 2013
d. California Wine Financing - 2008
e. Lionheart Cider* (distribution western states) - 2014
f. Leonhardt Oak Aged Beer - 2015
g. Leonhardt Vineyards LLC - 2000 Note - Leonhardt Vineyards is NOT part of Cal-X Stars Business Accelerator Inc. other than through the fact that Leonhardt Vineyards LLC DBA Leonhardt Ventures owns 50.1% of Cal-X Stars Business Accelerator Inc
Note - Startups in early stages in our incubator/accelerator are officially licensable technology platforms of Leonhardt Ventures (Leonhardt Vineyards LLC DBA Leonhardt Ventures) and Leonhardt Ventures' Cal-X Stars Business Accelerator Inc. until they are mature enough to stand on their own as a stand alone C corporation. Unit shares of licensable technology platforms will convert 1:1 to common stock shares once the startup is registered as a C corporation.
Cal-X Stars Business Accelerator Inc. is 50.1% owned by Leonhardt Ventures (Leonhardt Vineyards LLC DBA Leonhardt Ventures - Howard J. Leonhardt Founder) and 49.9% owned by 146 stakeholders which include our advisory board members compensated in shares or options.
*Cardiobridge - Leonhardt Ventures has a multistage conditional agreement in place to acquire up to 49.9% interest in Cardiobridge North America. Leonhardt Ventures has granted as a sub-part of this agreement 9% of its stake to Cal-X Stars Business Accelerator Inc.
*Wetling - Leonhardt Ventures has negotiated a conditional agreement with Wetling DK to distribute their wireless microcurrent devices into selected channel markets in the USA including peripheral vascular and diabetic foot ulcer treatment. The two teams are set to meet in May in Europe to finalize the North American product launch plan.
*Lucille's American Cafe's - Leonhardt Ventures owns 50% of the franchise rights trademark recipes SOPs and good will of Lucille's American Cafe's. Leonhardt Ventures owned 50% of original flagship Weston Florida restaurant from 2000 to 2013.
*Lionheart Cider - Leonhadt Ventures has negotiated a conditional agreement to participate in the distribution of Lionheart Cider in the western U.S. states including California Oregon Washington Arizona Colorado and Utah.
Media Relations Contact: Brian Hardy Fizzpopmedia email: brian@fizzpopmedia.com
Corporate Contact: Howard Leonhardt Executive Chairman email: hleonhardt@aol.com
Leonhardt Ventures
Cal-X Stars Business Accelerator Inc.
1531 6th Street Unit 401
Santa Monica CA 90401
(310) 310 2534
Cell 954 401 0096 (best)
Leonhardt's Launchpads Utah
489E 400 South Suite 116
Salt Lake City UT 84111
Leonhardt's Launchpads NorCal @ UNC STIC
@ University of Northern California Science Technology Innovation Center
1300 Valley House Dr Suite # 100-27
Rohnert Park CA 94928
Refer to Investor Relations Page for Risks and Warnings Within Our Private Placement Memorandum. Refer to Latest Newsletters for Updates. http://calxstars.com/investor-relations/
Securities offered under Rule 506(c) may be purchased only by accredited investors = persons with > $1 million in assets excluding their home and vehicles or whom have income > $200000 the past two years consecutively or > $300000 income as a couple. Accreditation status must be verified via documentation of credible third parties in a position to provide accurate verification. Investors in this offering should have experience in making early stage investments.
Cal-X Stars Business Accelerator Inc. develops early stage innovations and startups. By nature the risk is very high for these type of investments. Any investor should be fully prepared without reserve to lose all their investment. Our high focus on developing implantable devices and biologics for treating heart failure add exceptionally higher levels of risk as the products require multiple stages of clinical trials costing many millions of dollars and require high intellectual property protection to succeed commercially. The patent landscape in these areas of participation are wrought with potential for litigation. A high number of clinical trials in the heart failure space fail to prove greater safety and efficacy compared to currently available choices. A high number of early seed stage innovations fail to ever make it to market and even a smaller number become commercial successes. This type of investment is NOT appropriate for nest egg savings.
• The securities are being offered in reliance on an exemption from the registration requirements of the 150Securities Act and are not required to comply with specific disclosure requirements under the Securities Act; the Commission has not passed upon the merits of or given its approval to the securities the terms of the offering or the accuracy or completeness of any offering materials; the securities are subject to legal restrictions on transfer and resale and investors should not assume they will be able to resell their securities; and investing in securitiesinvolves risk and purchasers should be able to bear the loss of the entire investment. Private funds would be required to include a legend informing investors that the funds are not subject to the protections of the Investment Company Act.
Accuracy of Information Disclaimer: Representations and warranties – although we fully believe that our executive summaries newsletters websites and other written materials and videos accurately represent a true and accurate general high level picture of our activities history and progress – which is developing about 26 early stage un-proven cardiovascular life innovations and 4 early stage startup social good impact innovations (including new media social good projects) in an accelerator/incubator – we acknowledge that working with a very small core staff covering many thousands of pages of written materials across over 40 web sites with over 4000 sub-pages that we are highly prone to small errors outdated materials and a certain level on inaccuracy and inconsistencies even while fully striving for the utmost accuracy. Across the 30+ innovations and over 2000 working partnerships being developed there are changes and events that occur almost daily. We do our best to keep all websites and published materials fully up to date but recognize and make clear it is nearly impossible for our small staff to keep all materials on all web sites 100% up to date despite our best efforts to do so. Investors have the advantage with us that our small staff operates with a very low overhead but the offset disadvantage is that we do not have on hand the staffing to handle all the constant updates and proofreads needed to keep thousands of pages of materials up to date and 100% accurate 100% of the time. If you have ANY direct question about any published item of material interest to you – JUST ASK for clarification by emailing direct Howard Leonhardt at hleonhardt@aol.com or calling our office DIRECT LINE at 310 310 2534. We will strive to provide a clarification or update to you promptly.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.